Impact of Electronic Prescribing of Controlled Substances on Opioid Prescribing: Evidence From I-STOP Program in New York-Reference-Cited by-同舟云学术

Impact of Electronic Prescribing of Controlled Substances on Opioid Prescribing: Evidence From I-STOP Program in New York

Published:2021-03-11 Issue:1 Volume:79 Page:114-124
ISSN:1077-5587
Container-title:Medical Care Research and Review
language:en
Short-container-title:Med Care Res Rev

Author:

Pylypchuk Yuriy¹^ORCID,Parasrampuria Sonal²,Smiley Carmen¹,Searcy Talisha¹

Affiliation:

1. U.S. Department of Health and Human Services, Washington, DC, USA

2. Johns Hopkins University, Baltimore, MD, USA

Abstract

New York’s Internet System for Tracking Over-Prescribing (I-STOP) Act, requires prescribers in the state to electronically prescribe controlled substances (EPCS). We examine the effects of this mandate on prescribing patterns of opioids for Medicare Part D beneficiaries. Using 2014-2017 CMS Medicare Part D Prescriber Data, we apply a lagged dependent variable regression approach to identify the impact of I-STOP on the prescription of opioids. In the first year of implementation, the number of opioid prescriptions per prescriber decreased by 5.7 per year. The policy had a larger effect on the prescription of short-acting opioids and on prescribers prescribing medication for predominantly younger beneficiaries. Overall, I-STOP resulted in a reduction in the number of beneficiaries being prescribed opioids and in the number of opioid claims in the state of New York, suggesting positive implications for other states intending to curtail opioid overprescribing and misuse through the use of EPCS.

Publisher

SAGE Publications

Subject

Health Policy

Link

http://journals.sagepub.com/doi/pdf/10.1177/1077558721994994

Reference39 articles.

1. Mostly Harmless Econometrics

2. Bao Y., Wen K., Johnson P., Jeng P. J., Meisel Z. F., Schackman B. R. (2018). Assessing the impact of State Policies for Prescription Drug Monitoring Programs on high-risk opioid prescriptions. Health Affairs, 37(10), 1596-1604. https://doi.org/10.1377/hlthaff.2018.0512

3. Buchmueller T., Carey C. (2018). The effect of Prescription Drug Monitoring Programs on opioid utilization in Medicare. American Economic Journal: Economic Policy, 10(1), 77-112. https://doi.org/10.1257/pol.20160094

4. Burger M. (2018). The impact of cost on EPCS adoption. Point of Care Partners. https://www.pocp.com/hit-perspectives-cost-EPCS-Adoption

5. Centers for Medicare & Medicaid Services. (2018). Medicare fee-for-service provider utilization and payment data: Part D prescriber: Public use file: A methodological overview. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Medicare-Provider-Charge-Data/Downloads/Prescriber_Methods.pdf

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Public Health Informatics and the Perioperative Physician: Looking to the Future;Anesthesia & Analgesia;2024-01-12

2. The I‐STOP Program and Narcotic Prescriptions Following Facial Reconstructive Plastic Surgeries;The Laryngoscope;2023-08-10

3. Impact of state mandates on electronic prescribing of acute opioid prescriptions for the treatment of pain in Kansas and Colorado;Journal of the American Pharmacists Association;2023-07

4. Real-World Observational Evaluation of Common Interventions to Reduce Emergency Department Prescribing of Opioid Medications;The Joint Commission Journal on Quality and Patient Safety;2023-05

5. Trends in Prescribing Opioids, Benzodiazepines, and Both Among Adults with Alcohol Use Disorder in New York State;Journal of General Internal Medicine;2022-06-01